Swiss stocks - Factors to watch on February 1

ZURICH, Feb 1(Reuters) - The following are some of the main

factors expected to affect Swiss stocks on Wednesday.

Read more

BRIEF-Index Pharmaceuticals enters agreement with CRO for the conduct study

* Has entered an agreement for services with global Contract

Research Organization (CRO) parexel for implementation of

conduct study

Source text for Eikon:

Read more

BRIEF-Kukje Pharma says annual cash dividend for FY 2016

* Says it will pay annual cash dividend at 10 won/share for

FY 2016

Read more

BRIEF-Sanofi and Regeneron announce first approval of Kevzara

* Sanofi and Regeneron Pharmaceuticals, Inc. today

announced that Health Canada approved Kevzara(TM)

Read more

BRIEF-Oman's National Pharmaceutical Industries proposes 10 pct cash dividend

Feb 1 (Reuters) - National Pharmaceutical Industries Co Saog

:

Read more

BRIEF-Kuwait's Al Aman Investment to merge with Securities House

* Board approves to merge with Securities House

Source:(http://bit.ly/2koZVZa)

Further company coverage:

Read more

BRIEF-D.Western Therapeutics Institute to buy ophthalmic surgical adjuvant business from Healios KK

* Says the co to buy ophthalmic surgical adjuvant business,

which includes ingredient of Brilliant Blue G-250, from Healios

KK

Read more